Sfoglia per Autore
Neurons and ECM regulate occludin localization in brain endothelial cells
2000-01-01 Savettieri G.; Di Liegro I.; Catania C.; Licata L.; Pitarresi G.L.; D'Agostino S.; Schiera G.; De Caro V.; Giandalia G.; Giannola L.I.; Cestelli A.
Functional feature of a novel model of blood brain barrier: Studies on permeation of test compounds
2001-01-01 Cestelli A.; Catania C.; D'Agostino S.; Di Liegro I.; Licata L.; Schiera G.; Pitarresi G.L.; Savettieri G.; De Caro V.; Giandalia G.; Giannola L.I.
The passive mechanisms in a controlled release device.
2004-01-01 GIANNOLA LI
How a buccal device should deliver drugs: aspects of drug formulation related to taste and penetration enhancers
2004-01-01 GIANNOLA LI
Sintesi, caratterizzazione e studio della stabilità chimica ed enzimatica di nuovi profarmaci della dopamina
2004-01-01 GIANDALIA G; DE CARO V; SIRAGUSA MG; GIANNOLA LI
DOPAMINE PRO-DRUGS FOR CNS TARGETING: SYNTHESIS, CHARACTERIZATION AND HYDROLYSIS BY BRAIN ENZYMES.
2004-01-01 DE CARO V, GIANDALIA G, SIRAGUSA MG, GIANNOLA LI, SCHIERA G, PROIA P, AND DI LIEGRO I
A new delivery system of Clobetasol-17-propionate (lipid loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic-erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial,
2004-01-01 Campisi, G; Giandalia, G; De Caro, V; Di Liberto, C; Aricò, P'; Giannola, LI
Movement of drugs in biologic environment and through the membranes
2004-01-01 GIANNOLA LI
Drug movements in biologic environment and through the membranes
2004-01-01 GIANNOLA LI
Progettazione e realizzazione di sistemi di rilascio programmato nella terapia delle ferite da ustione
2004-01-01 SIRAGUSA MG; DE CARO V; GIANDALIA G; GIANNOLA LI
Naltrexone-loaded matrices: preparation, drug release and absorption through reconstituted buccal human epithelium
2004-01-01 GIANNOLA LI
Lipid Phase Transition in Saccharide-Coated Cholate-Containing Liposomes: Coupling to the Surrounding Matrix
2005-01-01 CHIANTIA S; GIANNOLA LI; CORDONE L
TRANSMUCOSAL PERMEABILITY MODEL OF AN OPIOD ANTAGONIST THROUGH PORCINE EPITHELIUM
2005-01-01 CAMPISI G; GIANNOLALI; WOLFFA
Transmucosal permeability model of 5-fluorouracil through porcine and reconstituted oral epithelium
2005-01-01 CAMPISI G; GIANNOLA LI; DE CARO V; GIANDALIA G; SIRAGUSA MG; WOLFF A
TRANSMUCOSAL PERMEABILITY MODEL OF 5-FLUOROURACIL THROUGH PORCINE AND RECOSTITUTED ORAL EPITHELIUM
2005-01-01 CAMPISI G; GIANNOLA LI; DE CARO V; GIANDALIA S SIRAGUSA G WOLFF A
Sistema electronico de administracion bucal de medicamentos para tratar addicin y enfermedades cronicas: ensayo en cerdos en el marco del proyecyo "IntelliDrug"
2005-01-01 WOLFF A; SCHUMACHER A; GOETTSCHE T; CIACH T; SELA Y; ARIELI M; FEDELE S; BEISKI BZ; CAMPISI G; GIANNOLA LI
Transmucosal permeability model of an opioid antagonist through porcine buccal mucosal epithelium
2005-01-01 CAMPISI G; GIANNOLA LI; WOLFF A
A three-cell type in vitro-model of BBB
2005-01-01 SCHIERA, G; PROIA, P; DE CARO, V; GIANDALIA, G; GIANNOLA, LI; ALBERTI, C; PITARRESI, GL; SAVETTIERI, G; DI LIEGRO, I
Movements of drugs in biological environment and thorough the membranes
2005-01-01 GIANNOLA LI
“In vitro studies, emphasis on the preparation of the drugs in matrices”.
2005-01-01 CAMPISI G; GIANNOLA LI
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile